The pharma industry is reported to be producing upwards of 48.6 tonnes of carbon dioxide per million US dollars of revenue, which is 55 per cent more than the carbon-intensive automotive industry. This statistic will be particularly concerning to the many pharma organizations that have committed to reducing their carbon emissions in an attempt to create environmentally friendly and sustainable pharmaceutical production and distribution processes.
In this report, Pharma IQ has collated the insights and advice from industry leaders and sustainability professionals from the likes of Sanofi, Boehringer Ingelheim and Dassault Systèmes to offer a closer look into the current state of sustainability in pharma and offer guidance for those attempting to drive sustainability in their own organizations.
Download this report to uncover:
- Why sustainability should be on the radar of every pharma organization
- How data and digital technologies can aid attempts to drive sustainability
- Three top tips from industry experts on how to drive sustainability in pharma